OCULAR THERAPEUTIX, INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
OCULAR THERAPEUTIX, INC (OCUL) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $13.90 million as of 2025-12-31, per its 10-K filed 2026-02-05.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-02-05
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $13.90M.
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $13.25M.
- 2014-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $852.00K.
- 2013-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $254.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2025-12-31 | $13.90M 10-K · filed 2026-02-05 |
| 2024-12-31 | $13.25M 10-K · filed 2026-02-05 |
| 2014-06-30 | $852.00K 10-Q · filed 2014-08-29 |
| 2013-12-31 | $254.00K 10-K · filed 2016-03-10 |
| 2012-12-31 | $268.00K 10-K · filed 2016-03-10 |
| 2011-12-31 | $219.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |